Literature DB >> 26279368

Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS/MS.

Xianqin Wang1, Shuanghu Wang2, Jianshe Ma3, Tao Ye4, Mengrou Lu5, Miao Fan4, Mingjie Deng1, Lufeng Hu6, Zhimou Gao7.   

Abstract

Berberrubine is an isoquinoline alkaloid isolated from Berberis vulgaris L, and it is readily derived from berberine. In this study, a sensitive and selective ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the determination of berberrubine in rat plasma and mouse tissue has been developed. Magnoflorine was employed as an internal standard (IS), and liquid-liquid extraction by ethyl acetate was used for sample preparation. Chromatographic separation was achieved on a UPLC BEH C18 column (2.1mm×100mm, 1.7μm) with 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. An electrospray ionization source was applied and operated in positive ion mode; multiple reactions monitoring (MRM) mode was used for quantification using target fragment ions m/z 322.0→307.0 for berberrubine and m/z 342.8→298.2 for IS. Calibration plots were linear in the range of 2-2000ng/mL for berberrubine in rat plasma and mouse tissue. Mean recoveries of berberrubine in rat plasma ranged from 79.6% to 84.8%. Intra-day and inter-day precision were less than 11%. The accuracy ranged from 93.6% to 106.8%. The method has also been successfully applied in pharmacokinetics and tissue distribution study of berberrubine. The absolute bioavailability of berberrubine was determined to be 31.6%. The results also show that berberrubine is rapidly absorbed and widely distributed in various tissues. The level of berberrubine in liver is highest, and followed by kidney, spleen and heart. Furthermore, the concentration of berberrubine in various tissues could also be predicted by a BP-ANN model.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BP-ANN; Berberrubine; Pharmacokinetics; Tissue distribution; UPLC-MS/MS

Mesh:

Substances:

Year:  2015        PMID: 26279368     DOI: 10.1016/j.jpba.2015.07.031

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.

Authors:  Na Yang; Run-Bin Sun; Xing-Long Chen; Le Zhen; Chun Ge; Yu-Qing Zhao; Jun He; Jian-Liang Geng; Jia-Hua Guo; Xiao-Yi Yu; Fei Fei; Si-Qi Feng; Xuan-Xuan Zhu; Hong-Bo Wang; Feng-Hua Fu; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

2.  Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity.

Authors:  Kai Wang; Jinqiu Rao; Tingting Zhang; Qing Gao; Jichao Zhang; Chenxi Guang; Liqin Ding; Feng Qiu
Journal:  Drug Des Devel Ther       Date:  2020-10-22       Impact factor: 4.162

3.  Effects of avitinib on the pharmacokinetics of osimertinib in vitro and in vivo in rats.

Authors:  Qingjun Wu; Hui Jiang; Shuanghu Wang; Dapeng Dai; Feifei Chen; Deru Meng; Peiwu Geng; Hongfeng Tong; Yunfang Zhou; Debiao Pan; Quan Zhou; Chunjie Wang
Journal:  Thorac Cancer       Date:  2020-08-19       Impact factor: 3.500

4.  Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota.

Authors:  Sa Yang; Shijie Cao; Congyu Li; Jichao Zhang; Chang Liu; Feng Qiu; Ning Kang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 5.  Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine.

Authors:  Hao Cheng; Juan Liu; Yuzhu Tan; Wuwen Feng; Cheng Peng
Journal:  J Pharm Anal       Date:  2021-10-21

6.  Inhibitory Effect of Lygodium Root on the Cytochrome P450 3A Enzyme in vitro and in vivo.

Authors:  Yunfang Zhou; Ailian Hua; Quan Zhou; Peiwu Geng; Feifei Chen; Lianhe Yan; Shuanghu Wang; Congcong Wen
Journal:  Drug Des Devel Ther       Date:  2020-05-19       Impact factor: 4.162

7.  Determination and pharmacokinetic study of AZD-3759 in rat plasma by ultra performance liquid chromatography with triple quadrupole mass spectrometer.

Authors:  Qingjun Wu; Ailian Hua; Yaoguang Sun; Chao Ma; Wenxin Tian; Chuan Huang; Hanbo Yu; Peng Jiao; Shuanghu Wang; Hongfeng Tong; Weiwen Qiu
Journal:  Thorac Cancer       Date:  2018-09-05       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.